$RTTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Qualigen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Qualigen Therapeutics, Inc.. Get notifications about new insider transactions in Qualigen Therapeutics, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | RTTR | Qualigen Therapeut ... | BROIDRICK AMY S. | EVP, Chief Strategy ... | Buy | P | 2.03 | 4,500 | 9,135 | 4,500 | 0 to 4.5 K |
Apr 21 2021 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, CEO & Pre ... | Buy | P | 1.80 | 11,005 | 19,809 | 11,005 | 0 to 11 K |
Apr 19 2021 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | Vice President of F ... | Buy | P | 1.86 | 2,700 | 5,022 | 12,541 | 9.8 K to 12.5 K (+27.44 %) |
Dec 30 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Buy | P | 2.94 | 4,000 | 11,740 | 10,000 | 6 K to 10 K (+66.67 %) |
Dec 29 2020 | RTTR | Qualigen Therapeut ... | BROIDRICK AMY S. | Executive VP, CSO | Option Exercise | A | 3.52 | 150,000 | 528,000 | 150,000 | |
Nov 23 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Buy | P | 3.46 | 4,600 | 15,925 | 6,000 | 1.4 K to 6 K (+328.57 %) |
Nov 23 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Buy | P | 3.55 | 1,400 | 4,969 | 1,400 | 0 to 1.4 K |
Nov 23 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Buy | P | 3.46 | 4,600 | 15,925 | 6,000 | 1.4 K to 6 K (+328.57 %) |
Nov 23 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Buy | P | 3.55 | 1,400 | 4,969 | 1,400 | 0 to 1.4 K |
Aug 28 2020 | RTTR | Qualigen Therapeut ... | BROIDRICK AMY S. | Director | Option Exercise | A | 4.70 | 50,000 | 235,000 | 50,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Ritter Ira E. | Director | Option Exercise | A | 5.13 | 50,000 | 256,500 | 50,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | David Richard A. | Director | Option Exercise | A | 5.13 | 50,000 | 256,500 | 50,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Option Exercise | A | 5.13 | 1,000,000 | 5,130,000 | 1,000,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Abdul-Ahad Wajdi | Vice President, R & ... | Option Exercise | A | 5.13 | 500,000 | 2,565,000 | 500,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Option Exercise | A | 5.13 | 50,000 | 256,500 | 50,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Sinha Shishir K. | Vice President of O ... | Option Exercise | A | 5.13 | 500,000 | 2,565,000 | 500,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Korenberg Matthew E | Director | Option Exercise | A | 5.13 | 50,000 | 256,500 | 50,000 | |
Jun 08 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | Vice President of F ... | Option Exercise | A | 5.13 | 600,000 | 3,078,000 | 600,000 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Abdul-Ahad Wajdi | VP, R&D, CSO | Option Exercise | J | 2.54 | 8,857 | 22,501 | 8,857 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Abdul-Ahad Wajdi | VP, R&D, CSO | Option Exercise | J | 2.07 | 7,971 | 16,470 | 7,971 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Sinha Shishir K. | Vice President of O ... | Option Exercise | J | 2.07 | 26,570 | 54,902 | 26,570 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Sinha Shishir K. | Vice President of O ... | Option Exercise | J | 2.07 | 8,857 | 18,301 | 8,857 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Option Exercise | J | 2.54 | 14,437 | 36,677 | 14,437 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Option Exercise | J | 2.54 | 22,142 | 56,252 | 22,142 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Option Exercise | J | 2.07 | 29,847 | 61,673 | 29,847 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Option Exercise | J | 2.07 | 22,142 | 45,752 | 22,142 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Poirier Michael S. | Chairman, President ... | Buy | J | 0.00 | 169,192 | 0 | 169,192 | 0 to 169.2 K |
May 27 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | VP of Finance, CFO. | Option Exercise | J | 2.54 | 3,543 | 9,001 | 3,543 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | VP of Finance, CFO. | Option Exercise | J | 2.54 | 22,142 | 56,252 | 22,142 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | VP of Finance, CFO. | Option Exercise | J | 2.07 | 29,847 | 61,673 | 29,847 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | VP of Finance, CFO. | Option Exercise | J | 2.07 | 22,142 | 45,752 | 22,142 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | Lotz Christopher L. | VP of Finance, CFO. | Buy | J | 0.00 | 9,841 | 0 | 9,841 | 0 to 9.8 K |
May 27 2020 | RTTR | Qualigen Therapeut ... | Kruger Kurt H | Director | Option Exercise | J | 2.54 | 8,857 | 22,501 | 8,857 | |
May 27 2020 | RTTR | Qualigen Therapeut ... | David Richard A. | Director | Option Exercise | J | 2.54 | 8,857 | 22,501 | 8,857 | |
May 19 2020 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | COB, CSO | Option Exercise | A | 0.64 | 361,502 | 231,361 | 361,502 | |
May 19 2020 | RTTR | RITTER PHARMACEUTI ... | Beck John W | Chief Financial Off ... | Option Exercise | A | 0.64 | 221,566 | 141,802 | 221,566 | |
May 19 2020 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | CEO and President | Option Exercise | A | 0.64 | 583,068 | 373,164 | 583,068 | |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | D | 1.30 | 38,461 | 49,999 | 0 | |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | C | 1.30 | 100 | 130 | 0 | |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Grant | A | 0.00 | 38,461 | 0 | 138,635 | 100.2 K to 138.6 K (+38.39 %) |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | C | 0.00 | 76,923 | 0 | 100,174 | 23.3 K to 100.2 K (+330.84 %) |
Mar 16 2020 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Sell | S | 0.22 | 500,000 | 110,000 | 704,780 | 1.2 M to 704.8 K (-41.50 %) |
Mar 16 2020 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Sell | S | 0.22 | 500,000 | 110,000 | 704,780 | 1.2 M to 704.8 K (-41.50 %) |
Mar 13 2020 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | COB, CSO | Sell | S | 0.38 | 18,750 | 7,043 | 81,727 | 100.5 K to 81.7 K (-18.66 %) |
Mar 13 2020 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | CEO and President | Sell | S | 0.38 | 18,750 | 7,043 | 81,727 | 100.5 K to 81.7 K (-18.66 %) |
Feb 27 2020 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | M | 0.15 | 500,000 | 75,000 | 0 | |
Feb 27 2020 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Buy | M | 0.15 | 500,000 | 75,000 | 1,204,780 | 704.8 K to 1.2 M (+70.94 %) |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | Beck John W | Chief Financial Off ... | Option Exercise | A | 0.60 | 105,000 | 63,000 | 105,000 | |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | CEO and President | Option Exercise | A | 0.60 | 252,000 | 151,200 | 252,000 | |
Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 38,461 | 49,999 | 38,461 | |
Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 100 | 130 | 100 | |
Aug 20 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 2.04 | 19,751 | 40,292 | 54,751 | 35 K to 54.8 K (+56.43 %) |
Jun 27 2018 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | CEO and President | Option Exercise | A | 2.73 | 150,000 | 409,500 | 150,000 | |
May 25 2018 | RTTR | RITTER PHARMACEUTI ... | Beck John W | Chief Financial Off ... | Option Exercise | A | 3.32 | 100,000 | 332,000 | 100,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | PROEHL GERALD T | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | PROEHL GERALD T | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | A | 0.34 | 495,065 | 168,322 | 495,065 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Benjamin Jeffrey S | VP of Finance | Option Exercise | A | 0.34 | 124,000 | 42,160 | 124,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | Benjamin Jeffrey S | VP of Finance | Option Exercise | A | 0.34 | 124,000 | 42,160 | 124,000 | |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | P | 0.44 | 187,500 | 82,500 | 187,500 | |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Buy | P | 0.00 | 187,500 | 0 | 1,004,772 | 817.3 K to 1 M (+22.94 %) |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | P | 0.44 | 187,500 | 82,500 | 187,500 | |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Buy | P | 0.00 | 187,500 | 0 | 1,004,772 | 817.3 K to 1 M (+22.94 %) |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | P | 0.44 | 5,000,000 | 2,200,000 | 5,000,000 | |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Buy | P | 0.00 | 5,000,000 | 0 | 7,047,804 | 2 M to 7 M (+244.16 %) |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners, L.P. | 10% Owner | Option Exercise | P | 0.44 | 5,000,000 | 2,200,000 | 5,000,000 | |
Oct 27 2017 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners, L.P. | 10% Owner | Buy | P | 0.00 | 5,000,000 | 0 | 7,047,804 | 2 M to 7 M (+244.16 %) |
May 18 2017 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 0.62 | 18,000 | 11,155 | 35,000 | 17 K to 35 K (+105.88 %) |
May 12 2017 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Buy | P | 0.62 | 13,000 | 8,007 | 50,000 | 37 K to 50 K (+35.14 %) |
Feb 01 2017 | RTTR | RITTER PHARMACEUTI ... | Merino William M. | Director | Option Exercise | A | 2.89 | 10,000 | 28,900 | 10,000 | |
Jan 27 2017 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Option Exercise | A | 2.89 | 58,000 | 167,620 | 58,000 | |
Jan 27 2017 | RTTR | RITTER PHARMACEUTI ... | Mochizuki Ellen F. | VP, Finance | Option Exercise | A | 2.89 | 15,000 | 43,350 | 15,000 | |
Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | PROEHL GERALD T | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
Oct 25 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | A | 2.60 | 140,044 | 364,114 | 140,044 | |
Oct 25 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | A | 2.60 | 140,044 | 364,114 | 140,044 | |
Jul 07 2016 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Option Exercise | A | 1.54 | 82,000 | 126,280 | 82,000 | |
Jul 07 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | A | 1.54 | 82,000 | 126,280 | 82,000 | |
Jul 07 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | A | 1.54 | 82,000 | 126,280 | 82,000 | |
Feb 24 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Buy | P | 1.60 | 6,250 | 10,000 | 6,250 | 0 to 6.3 K |
Feb 24 2016 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Buy | P | 1.60 | 6,250 | 10,000 | 6,250 | 0 to 6.3 K |
Jan 29 2016 | RTTR | RITTER PHARMACEUTI ... | Mochizuki Ellen F. | VP, Finance | Option Exercise | A | 1.39 | 10,000 | 13,900 | 10,000 | |
Jan 11 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 1.64 | 13,000 | 21,320 | 17,000 | 4 K to 17 K (+325.00 %) |
Jan 08 2016 | RTTR | RITTER PHARMACEUTI ... | Step Michael D | CEO | Buy | P | 1.48 | 27,000 | 39,960 | 27,000 | 0 to 27 K |
Oct 15 2015 | RTTR | RITTER PHARMACEUTI ... | MAIER PAUL V | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Oct 15 2015 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Oct 15 2015 | RTTR | RITTER PHARMACEUTI ... | PROEHL GERALD T | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Stonehenge Partners LLC | 10% Owner | Option Exercise | C | 0.00 | 817,272 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Stonehenge Partners LLC | 10% Owner | Buy | C | 0.00 | 817,272 | 0 | 817,272 | 0 to 817.3 K |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Option Exercise | C | 0.00 | 817,272 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Ritter Ira E. | Exec. Chairman, CSO | Buy | C | 0.00 | 817,272 | 0 | 817,272 | 0 to 817.3 K |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Option Exercise | C | 0.00 | 817,272 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Ritter Andrew J | President | Buy | C | 0.00 | 817,272 | 0 | 817,272 | 0 to 817.3 K |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners I SPV ... | 10% Owner | Option Exercise | C | 0.00 | 322,753 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners I SPV ... | 10% Owner | Buy | C | 0.00 | 322,753 | 0 | 322,753 | 0 to 322.8 K |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,247,804 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners, L.P. | 10% Owner | Buy | C | 0.00 | 1,247,804 | 0 | 2,047,804 | 800 K to 2 M (+155.98 %) |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | C | 0.00 | 322,753 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Option Exercise | C | 0.00 | 1,247,804 | 0 | 0 | |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Buy | C | 0.00 | 322,753 | 0 | 322,753 | 0 to 322.8 K |
Jun 30 2015 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Buy | C | 0.00 | 1,247,804 | 0 | 2,047,804 | 800 K to 2 M (+155.98 %) |
Jun 25 2015 | RTTR | RITTER PHARMACEUTI ... | Javelin Venture Partners, L.P. | 10% Owner | Buy | P | 5.00 | 800,000 | 4,000,000 | 800,000 | 0 to 800 K |
Jun 25 2015 | RTTR | RITTER PHARMACEUTI ... | Doyle Noah | Director | Buy | P | 5.00 | 800,000 | 4,000,000 | 800,000 | 0 to 800 K |
Jun 25 2015 | RTTR | RITTER PHARMACEUTI ... | PROEHL GERALD T | Director | Buy | P | 5.00 | 50,000 | 250,000 | 50,000 | 0 to 50 K |
Jun 25 2015 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 5.00 | 4,000 | 20,000 | 4,000 | 0 to 4 K |
Page: 1